Abivax SA Sponsored ADR (NASDAQ:ABVX) Given Average Rating of "Moderate Buy" by Brokerages
MarketBeat
Exagen Inc. (NASDAQ:XGN) Receives Consensus Recommendation of "Moderate Buy" from Analysts
MarketBeat
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Given Average Rating of "Moderate Buy" by Brokerages
MarketBeat
Essity's CFO to retire during 2027
PR Newswire
Regeneron Pharmaceuticals (NASDAQ:REGN) Rating Increased to Strong-Buy at Wall Street Zen
The Cerbat Gem
Societe Generale Issues 2029 Financial Targets; To Pursue Cost Reduction Efforts
Nasdaq News: Markets
